All About Multiple Sclerosis

More MS news articles for May 2004

Heterogeneous expression of CD59 on human Purkinje cells

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15147772

Neurosci Lett. 2004 May 13;362(1):21-5
Storstein A, Knudsen A, Bjorge L, Meri S, Vedeler C.
Department of Neurology, Haukeland University Hospital, N-5021 Bergen, Norway.

The expression of CD59 and other complement regulators was studied in human cerebellum from 14 individuals with no cerebellar pathology, from one patient with multiple sclerosis (MS) and from two patients with paraneoplastic cerebellar degeneration (PCD).

CD59 was present on the Purkinje cells at various levels in eight of the 14 cases with no cerebellar pathology.

CD59 was also present on the Purkinje cells of the patient with MS, but not on the scarce remaining Purkinje cells of the two patients with PCD.

Other complement regulators (CD35, CD46 and CD55) were not expressed on the Purkinje cells, whereas CD59, CD46 and CD55 were present on the molecular, granulosa and endothelial cells.

The results suggest that Purkinje cells not expressing CD59 could be especially prone to complement-mediated damage.